105 related articles for article (PubMed ID: 8401258)
1. The biology of interleukin 11.
Neben S; Turner K
Stem Cells; 1993 Jul; 11 Suppl 2():156-62. PubMed ID: 8401258
[TBL] [Abstract][Full Text] [Related]
2. Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity.
Goldman SJ
Stem Cells; 1995 Sep; 13(5):462-71. PubMed ID: 8528095
[TBL] [Abstract][Full Text] [Related]
3. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
4. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
5. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor.
Fourcin M; Chevalier S; Lebrun JJ; Kelly P; Pouplard A; Wijdenes J; Gascan H
Eur J Immunol; 1994 Jan; 24(1):277-80. PubMed ID: 8020567
[TBL] [Abstract][Full Text] [Related]
6. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 11: an overview.
Yang YC
Stem Cells; 1993 Nov; 11(6):474-86. PubMed ID: 8111307
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-11 and its receptor.
Yang YC; Yin T
Biofactors; 1992 Dec; 4(1):15-21. PubMed ID: 1292471
[TBL] [Abstract][Full Text] [Related]
10. A ciliary neurotrophic factor-sensitive human myeloma cell line.
Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B
Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture.
Sammons J; Ahmed N; Khokher MA; Hassan HT
Stem Cells; 2000; 18(3):214-9. PubMed ID: 10840075
[TBL] [Abstract][Full Text] [Related]
12. [Function, molecular structure and gene expression of interleukin-11 (IL-11/AGIF)].
Kawashima I; Ohsumi J; Miyadai K; Takiguchi Y
Nihon Rinsho; 1992 Aug; 50(8):1833-9. PubMed ID: 1433976
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a potent human interleukin-11 agonist.
Harmegnies D; Wang XM; Vandenbussche P; Leon A; Vusio P; Grötzinger J; Jacques Y; Goormaghtigh E; Devreese B; Content J
Biochem J; 2003 Oct; 375(Pt 1):23-32. PubMed ID: 12919066
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-11 signaling is required for the differentiation of natural killer cells at the maternal-fetal interface.
Ain R; Trinh ML; Soares MJ
Dev Dyn; 2004 Dec; 231(4):700-8. PubMed ID: 15499555
[TBL] [Abstract][Full Text] [Related]
15. The role of recombinant interleukin 11 in megakaryocytopoiesis.
Turner KJ; Neben S; Weich N; Schaub RG; Goldman SJ
Stem Cells; 1996; 14 Suppl 1():53-61. PubMed ID: 11012203
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage.
Taguchi Y; Yamamoto M; Yamate T; Lin SC; Mocharla H; DeTogni P; Nakayama N; Boyce BF; Abe E; Manolagas SC
Proc Assoc Am Physicians; 1998; 110(6):559-74. PubMed ID: 9824538
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice.
Nitsche A; Junghahn I; Thulke S; Aumann J; Radonić A; Fichtner I; Siegert W
Stem Cells; 2003; 21(2):236-44. PubMed ID: 12634420
[TBL] [Abstract][Full Text] [Related]
18. Review of a novel hematopoietic cytokine, interleukin-11.
Quesniaux VF; Mayer P; Liehl E; Turner K; Goldman SJ; Fagg B
Int Rev Exp Pathol; 1993; 34 Pt A():205-14. PubMed ID: 8454414
[TBL] [Abstract][Full Text] [Related]
19. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
[TBL] [Abstract][Full Text] [Related]
20. In vitro expansion of murine hematopoietic progenitor cells by leukemia inhibitory factor, stem cell factor, and interleukin-1 beta.
Imamura M; Zhu X; Han M; Kobayashi M; Hashino S; Tanaka J; Kobayashi S; Kasai M; Asaka M
Exp Hematol; 1996 Sep; 24(11):1280-8. PubMed ID: 8862438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
